MUCOSIN TABLET 30mg tablets ZENTIVA
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Find medicines for human use by name or active substance.
Browse by initial
1,201–1,220 of 1,296 medicines
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: carbocisteine
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: carbocisteine
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: carbocisteine
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: dronedarone
C01BD07 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class III
Indicated for: cardiac arrhythmias
Active substance: combinations
B05ZBN3 Blood and blood forming organs | Hemodialytics and hemofiltrates | Hemofiltrates
Indicated for: various therapeutic indications
Active substance: combinations
B05ZBN3 Blood and blood forming organs | Hemodialytics and hemofiltrates | Hemofiltrates
Indicated for: various therapeutic indications
Active substance: interferon alfa (HuIFN-alfa-Le)
Indicated for: viral infections; multiple sclerosis; cancer
Active substance: natural alfa interferon
Indicated for: viral infections; multiple sclerosis; cancer
Active substance: gadobenic acid
V08CA08 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: gadobenic acid
V08CA08 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: gadobenic acid
V08CA08 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.